10x Genomics (TXG) Retained Earnings (2018 - 2026)

10x Genomics (TXG) has 9 years of Retained Earnings data on file, last reported at $114000.0 in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 100.01% year-over-year to $114000.0; the trailing twelve-month figure through Mar 2026 stood at $114000.0 (up 100.01% YoY), and the FY2025 full-year result was -$1.5 billion, down 306307.91% from the prior year.
• Retained Earnings climbed to $114000.0 in Q1 2026, from -$1.5 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $114000.0 in Q1 2026 to a low of -$1.5 billion in Q4 2025.
• A 5-year average of -$868.3 million and a median of -$1.2 billion in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 4678831.82% in 2022 and jumped 100.01% in 2026, its largest moves.
• Tracing TXG's Retained Earnings over 5 years: stood at -$1.0 billion in 2022, then declined by 24.78% to -$1.3 billion in 2023, then surged by 99.96% to -$493000.0 in 2024, then tumbled by 306307.91% to -$1.5 billion in 2025, then jumped by 100.01% to $114000.0 in 2026.
• Business Quant data shows TXG's Retained Earnings at $114000.0 in Q1 2026, -$1.5 billion in Q4 2025, and -$1.5 billion in Q3 2025.